3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazol-3-yl]formamido}butanamide
Structure Info
- Chemspace ID
- CSSB14863685459 (In-Stock Building Blocks)
- IUPAC Name
- 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazol-3-yl]formamido}butanamide
- Mol formula
- C19H26N4O2
- Mol weight
- 342 Da
- Catalog Number(s)
- AA01XH9A, AG01XHC2, BG41530, ST01XISU, TX01XIHQ
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.85
- Heavy atoms count
- 25
- Rotatable bond count
- 8
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.421
- Polar surface area (Å)
- 90
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSB14863685459
Items Overall 10 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 mg | 115.50 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 5 mg | 403.70 | |
Description: ADB-4en-PINACA; CAS: 2666932-44-9 | ||||||
| Angene US | 10 days | United States To: | 98 | 1 mg | 140.40 | |
| Angene US | 10 days | United States To: | 98 | 5 mg | 491.40 | |
Description: ADB-4en-PINACA; CAS: 2666932-44-9 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 1 mg | 125.35 | |
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 439.30 | |
Description: ADB-4en-PINACA; CAS: 2666932-44-9 | ||||||
| AA BLOCKS | 12 days | United States To: | 98 | 1 mg | 134.20 | |
| AA BLOCKS | 12 days | United States To: | 98 | 5 mg | 467.50 | |
Description: ADB-4en-PINACA; CAS: 2666932-44-9 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 1 mg | 97.90 | |
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 339.90 | |
Description: ADB-4en-PINACA; CAS: 2666932-44-9 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of (2S)-2-[(1-hexyl-1H-indazol-3-yl)formamido]-3,3-dimethylbutanamide - CSSB21511131853](/st/structure/200/f937dd95294cbd1efa0de9bd45f0f071/CCCCCCN1N%253DC%2528C%2528%253DO%2529N%255BC%2540H%255D%2528C%2528N%2529%253DO%2529C%2528C%2529%2528C%2529C%2529C2%253DCC%253DCC%253DC12.png)
![Chemical structure of 2-{[1-(5-hydroxypentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanamide - CSSB00159239753](/st/structure/200/d1848a550b2274a9a83d569b837374f5/CC%2528C%2529%2528C%2529C%2528NC%2528%253DO%2529C1%253DNN%2528CCCCCO%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO.png)
![Chemical structure of 2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanamide - CSSB00161154381](/st/structure/200/a02f525e0d2db21796a4c69f60688f3d/CC%2528C%2529%2528C%2529C%2528NC%2528%253DO%2529C1%253DNN%2528CCCCCF%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO.png)
![Chemical structure of 4-(3-{[(1S)-1-carbamoyl-2,2-dimethylpropyl]carbamoyl}-1H-indazol-1-yl)butanoic acid - CSSB00160812649](/st/structure/200/a6af370cbfbac6eeaf61e75e7c2fae24/CC%2528C%2529%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CCCC%2528O%2529%253DO%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO.png)
![Chemical structure of 2-{[1-(4-hydroxypentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanamide - CSSB00159239750](/st/structure/200/10d5e3915d02610378e7f7d30a3df6d4/CC%2528O%2529CCCN1N%253DC%2528C%2528%253DO%2529NC%2528C%2528N%2529%253DO%2529C%2528C%2529%2528C%2529C%2529C2%253DCC%253DCC%253DC12.png)
![Chemical structure of 5-{3-[(1-carbamoyl-2,2-dimethylpropyl)carbamoyl]-1H-indazol-1-yl}pentanoic acid - CSSB06657276435](/st/structure/200/975a8ecd918ecae04be65b8302f00e1a/CC%2528C%2529%2528C%2529C%2528NC%2528%253DO%2529c1nn%2528CCCCC%2528O%2529%253DO%2529c2ccccc12%2529C%2528N%2529%253DO.png)
![Chemical structure of 2-[(1-benzyl-1H-indazol-3-yl)formamido]-3,3-dimethylbutanamide - CSSB06629244450](/st/structure/200/894394cd04e6d1e048c11810a78bfdcc/CC%2528C%2529%2528C%2529C%2528NC%2528%253DO%2529c1nn%2528Cc2ccccc2%2529c2ccccc12%2529C%2528N%2529%253DO.png)
